Polyprodrug with Glutathione Depletion and Cascade Drug Activation for Multi-drug Resistance Reversal
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Polyprodrug with Glutathione Depletion and Cascade Drug Activation for Multi-drug Resistance Reversal
Authors
Keywords
Glutathione response, Multidrug resistance, poly(disulfide)
Journal
BIOMATERIALS
Volume -, Issue -, Pages 120649
Publisher
Elsevier BV
Online
2021-01-08
DOI
10.1016/j.biomaterials.2020.120649
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Redox-responsive polyprodrug nanoparticles for targeted siRNA delivery and synergistic liver cancer therapy
- (2020) Senlin Li et al. BIOMATERIALS
- A mitochondria-targeting magnetothermogenic nanozyme for magnet-induced synergistic cancer therapy
- (2020) Jinchao Shen et al. BIOMATERIALS
- Stimuli-responsive prodrug-based cancer nanomedicine
- (2020) Angel Xie et al. EBioMedicine
- Synthesis of Ultrathin Biotite Nanosheets as an Intelligent Theranostic Platform for Combination Cancer Therapy
- (2019) Xiaoyuan Ji et al. Advanced Science
- Synthetic mRNA nanoparticle-mediated restoration of p53 tumor suppressor sensitizes p53-deficient cancers to mTOR inhibition
- (2019) Na Kong et al. Science Translational Medicine
- Simultaneous Fenton-like Ion Delivery and Glutathione Depletion by MnO2 -Based Nanoagent to Enhance Chemodynamic Therapy
- (2018) Li-Sen Lin et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- A glutathione-responsive sulfur dioxide polymer prodrug as a nanocarrier for combating drug-resistance in cancer chemotherapy
- (2018) Wei Shen et al. BIOMATERIALS
- Intracellular glutathione-depleting polymeric micelles for cisplatin prodrug delivery to overcome cisplatin resistance of cancers
- (2018) Yu Han et al. JOURNAL OF CONTROLLED RELEASE
- Glutathione-Scavenging Poly(disulfide amide) Nanoparticles for the Effective Delivery of Pt(IV) Prodrugs and Reversal of Cisplatin Resistance
- (2018) Xiang Ling et al. NANO LETTERS
- Stimuli-Responsive Nanomedicines for Overcoming Cancer Multidrug Resistance
- (2018) Lei Zhou et al. Theranostics
- Glutathione-Responsive Prodrug Nanoparticles for Effective Drug Delivery and Cancer Therapy
- (2018) Xiang Ling et al. ACS Nano
- Modulating ROS to overcome multidrug resistance in cancer
- (2018) Qingbin Cui et al. DRUG RESISTANCE UPDATES
- Structural diversity in poly(disulfide)s
- (2017) Raju Bej et al. JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
- Dual delivery of biological therapeutics for multimodal and synergistic cancer therapies
- (2016) Bora Jang et al. ADVANCED DRUG DELIVERY REVIEWS
- GSH-targeted nanosponges increase doxorubicin-induced toxicity “in vitro” and “in vivo” in cancer cells with high antioxidant defenses
- (2016) Martina Daga et al. FREE RADICAL BIOLOGY AND MEDICINE
- Hyperbranched Self-Immolative Polymers (hSIPs) for Programmed Payload Delivery and Ultrasensitive Detection
- (2015) Guhuan Liu et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells
- (2015) N Mohell et al. Cell Death & Disease
- Nanopreparations to overcome multidrug resistance in cancer
- (2013) Niravkumar R. Patel et al. ADVANCED DRUG DELIVERY REVIEWS
- Stimuli-responsive nanocarriers for drug delivery
- (2013) Simona Mura et al. NATURE MATERIALS
- Doxorubicin-Tethered Responsive Gold Nanoparticles Facilitate Intracellular Drug Delivery for Overcoming Multidrug Resistance in Cancer Cells
- (2011) Feng Wang et al. ACS Nano
- Cellular Redox Pathways as a Therapeutic Target in the Treatment of Cancer
- (2011) Alberto J. Montero et al. DRUGS
- Redox-Directed Cancer Therapeutics: Molecular Mechanisms and Opportunities
- (2009) Georg T. Wondrak ANTIOXIDANTS & REDOX SIGNALING
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More